News - Page 201 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

Post published:March 15, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies Shed Cannabis Assets

Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies Shed Cannabis Assets

Post published:March 12, 2021
Post category:Psychedelic Bulletin

Read more about the article Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

Post published:March 11, 2021
Post category:Press Release

Read more about the article Octarine Bio announces closing of extended seed round financing of $1.2 million USD with an uptick in valuation due to significant investor demand.

Octarine Bio announces closing of extended seed round financing of $1.2 million USD with an uptick in valuation due to significant investor demand.

Post published:March 11, 2021
Post category:Press Release

Read more about the article BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

Post published:March 11, 2021
Post category:Press Release

Read more about the article NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

Post published:March 11, 2021
Post category:Press Release

Read more about the article Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Post published:March 10, 2021
Post category:Press Release

Read more about the article DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a Study as First Clinical Trial in Opioid Use Disorder in the UK

DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a Study as First Clinical Trial in Opioid Use Disorder in the UK

Post published:March 10, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Post published:March 10, 2021
Post category:Press Release

Read more about the article MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m)

MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m)

Post published:March 9, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.